Kumar Somyajit is Associate Professor at the University of Southern Denmark's Department of Biochemistry and Molecular Biology. He leads research on DNA replication and genome surveillance mechanisms using mammalian cell models. Research focuses on: Metabolic regulation of DNA replication Replisome plasticity under stress Homology-directed repair mechanisms Chromatin dynamics in cancer Recipient of Lundbeck Foundation Fellowship (2021). Current projects investigate metabolic coupling to genome surveillance in cancer and development. Supervises PhD students in DNA repair and replication studies.
Zorana Jovanovic Andersen is an Associate Professor at the University of Copenhagen, Department of Public Health, Section of Environmental Health, specializing in Environmental and Occupational Epidemiology. Her research focuses on health impacts of air pollution , noise exposure , and lifestyle factors across large cohorts including the Danish Nurse Cohort and Diet, Health, and Cancer cohort. Primary research areas: Environmental Epidemiology, Breast Cancer Risk, Air Pollution, Noise Studies, Physical Activity Interactions Key projects: Hyperion (road traffic noise), ELAPSE (low-level air pollution), TAPAS (climate-transportation health risks) Research Themes She investigates long-term exposure to air pollution and noise in relation to breast cancer , diabetes , cardiovascular disease , and brain cancer , while exploring how factors like physical activity modify these risks. Recent work includes dementia and COVID-19 mortality analyses. Scientific Contributions Her 15 most recent publications address: 1) Air pollution disparities in Europe 2) Dementia-air pollution links 3) Stroke-noise interactions 4) Airport ultrafine particle exposure 5) Asthma-COPD overlap 6) Breast cancer-mammographic density relationships. Major Grants Danish Working Environment Research Fund (1.79M DKK, 2017) Danish Heart Association (433K DKK, 2016) Danish Council for Independent Research (1.93M DKK, 2015) Teaching & Leadership Course Leader for Data Processing in Health Care and Public Health Informatics at UCPH since 2011. Organized Danish Health Registries seminars and served on scientific committees for environmental conferences.
Henrik Møller is a Professor at the Danish Center for Health Services Research , part of the Faculty of Health Sciences at Aalborg University . His work focuses on cancer epidemiology , clinical quality registries , and health services research , particularly examining prostate cancer , lung cancer , and colorectal cancer through nationwide cohort studies. Key research areas: Cancer care quality, pandemic impacts on diagnosis/treatment, socioeconomic disparities Active collaborations in Denmark and England Contributor to national and international cancer registries Recent publications analyze CT imaging trends in lung cancer detection, chemotherapy disparities in pancreatic cancer, and genetic biomarkers in gliomas. His team has released multiple datasets on figshare platforms. As a leader in health services research, Møller's work informs healthcare policy improvements through evidence-based quality indicators and development targets.
Kars van der Weijden is an academic researcher affiliated with the Faculty of Medical Sciences at the University of Groningen , working within the Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE) department. Their primary research focuses on neuroimaging methodologies, particularly PET and MRI techniques, applied to neurological disorders such as multiple sclerosis and brain tumors. Key areas include myelin imaging, diffusion-weighted imaging validation, and artifact reduction in clinical MRI. They contribute to the UN Sustainable Development Goals, specifically targeting SDGs related to good health and well-being. Research highlights include developing non-invasive imaging tools like [11C]MeDAS PET for myelin loss assessment and exploring the future of PET imaging in characterizing white matter lesions. Their work bridges translational research between animal models and clinical applications. Recent activities include reviewing cognitive impairments post-radiotherapy and advancing open science initiatives through memberships in Open Science Initiative for Perfusion Imaging (OSIPI) and GliMR . Awards include the 2024 MS Research Stichting and Research School of Behavioural and Cognitive Neurosciences recognition.
Sune Darkner is a Professor at the Department of Computer Science (DIKU) at the University of Copenhagen, specializing in the Image Analysis, Computational Modelling, and Geometry research section. His work focuses on medical image processing with particular emphasis on neuro-imaging data including MRI and PET scans. His primary research interests include Image Registration, Segmentation and Classification of Medical Image Data , with a specific focus on estimation of image similarity as his main research interest. Darkner strongly believes that the implementation of image processing algorithms should be thoroughly tested and reflect the theoretical properties as accurately as possible. His work primarily centers on neuro-imaging data such as MRI and PET. His recent publications (2024-2025) reveal a strong focus on medical image analysis, with particular emphasis on tumor volume delineation, deformable image registration with physics constraints, and applications of deep learning in medical imaging. His work spans both theoretical foundations of image processing and practical clinical applications. Darkner previously held a Post Doc position at the Technical University of Denmark from February 2009 to January 2010, demonstrating his longstanding engagement with image analysis research in the Danish academic community.
Volkert Dirk Siersma is an External Lecturer in the Department of Public Health, Section of Biostatistics at the University of Copenhagen's Faculty of Health and Medical Sciences. He is affiliated with the Research Unit for General Practice (Forskningsenheden for Almen Praksis) and has an extensive publication record with 409 research outputs documented. Dr. Siersma is a statistician specializing in quantitative analyses for medical research projects. His methodological expertise focuses on graphical models and longitudinal data analysis methods for data collected repeatedly over time periods. His research spans multiple medical disciplines including anesthesiology, primary care, infectious disease, oncology, and geriatrics. His recent work (2025) demonstrates strong engagement in clinical trials methodology, with publications appearing in high-impact journals including JAMA, The Lancet Regional Health - Europe, and BMC Primary Care. His research often involves international collaborations and addresses practical clinical questions with implications for healthcare practice and policy. Dr. Siersma has contributed to studies examining oxygen therapy in trauma patients, antibiotic stewardship in pediatric care, patient-centeredness measurement tools, and deprescribing practices in dementia care, reflecting the breadth of his biostatistical applications across medical specialties.
Barbara Guerra is an Associate Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, Faculty of Science. She leads the Barbara Guerra Lab, which is part of the Translational Biology research section, focusing on the role of protein kinases in human disease, particularly cancer. She also serves as Head of the PhD School at the Faculty of Science since 2020, demonstrating strong leadership in academic training and research supervision. Her research expertise lies in protein kinase CK2, a key regulator of cell survival, growth, and differentiation. Her laboratory investigates CK2-mediated signaling pathways in cancer, DNA damage response, lipid metabolism, and cell cycle regulation. She has contributed extensively to understanding CK2's role in oncogenesis and its potential as a therapeutic target. Her recent publications reveal a consistent focus on CK2 in cancer metabolism, hypoxia signaling (e.g., HIF-1α), autophagy, and the development of kinase inhibitors. Themes include pharmacological targeting of CK2, regulation of metabolic enzymes like SCD-1, and modulation of tumor suppressors such as p27KIP1. She frequently collaborates on interdisciplinary studies involving drug delivery systems and natural product-based inhibitors. Barbara Guerra has received recognition for her teaching excellence, including a Faculty of Natural Science teaching prize in 2006. She serves on the editorial boards of Oncology Reports and Pharmaceuticals , contributing to scientific peer review and dissemination. She has supervised over 100 undergraduate, Master’s, and PhD students, as well as six postdoctoral researchers, indicating a strong commitment to mentoring the next generation of scientists. Her research is supported by numerous projects and she plays a central role in PhD education at the university level. Her lab is actively involved in translational research, bridging basic molecular mechanisms with potential clinical applications in oncology and metabolic disorders.
Rene Johannes Laursen is a Clinical Professor at Aalborg University, holding a dual role as Chief Physician (Ledende overlæge) in the Department of Neurosurgery at Aalborg University Hospital. His academic appointment within the Faculty of Medicine underscores his integration of clinical practice, research, and teaching in neurosurgical oncology. Research Interests: Dr. Laursen's work is centered on improving outcomes for brain tumor patients, with a focus on glioblastoma. His research encompasses: Optimization of Tumor Treating Fields therapy combined with surgical interventions Skull remodeling techniques for recurrent glioblastoma Regional and socio-economic disparities in glioblastoma survival Precision medicine applications in late-stage cancer care Publication Trends: Recent publications (2022-2024) highlight his leadership in the OPTIMALTTF-2 multi-center clinical trial, which investigates skull surgery combined with TTFields for recurrent glioblastoma. His studies also address real-world challenges in neuro-oncology, including the feasibility of precision medicine in regional hospitals and population-based survival analysis in Denmark. Professional Engagement: Dr. Laursen actively contributes to the field through memberships in the Danish Neurosurgical Society (DNKS) committees and the European Association of Neuro-Oncology (EANO). These roles facilitate collaboration on national and international neuro-oncology research initiatives. Scientific Awards: No awards were specified in the available information. Advising and Grants: Details regarding student supervision or research funding were not provided. Laboratories and Teams: He participates in multi-disciplinary neurosurgery and neuro-oncology teams at Aalborg University Hospital, driving clinical innovation through collaborative research projects and trials.
Ian F. Parney, M.D., Ph.D., is a Professor of Neurosurgery at Mayo Clinic in Rochester, Minnesota, where he also serves as Vice Chair for Research in the Department of Neurologic Surgery and Mayo Clinic Enterprise Chair for Neurosurgery Research. He is affiliated with the Mayo Clinic Alix School of Medicine and holds a joint appointment in the Department of Immunology. His clinical expertise is in malignant brain tumor surgery, including glioblastomas, metastatic tumors, and meningiomas, with advanced techniques such as awake brain surgery, intraoperative MRI, and laser ablation. Dr. Parney earned his BSc and MD from the University of Alberta, followed by a PhD in Experimental Surgery, and completed clinical and research fellowships at the University of California, San Francisco. His research is centered on three themes: improving glioma surgery through advanced imaging and guidance, understanding glioblastoma immunology, and developing effective immunotherapies such as dendritic cell vaccines. His lab uses patient-derived models, humanized mice, and collaborations with the Mayo Clinic Human Cellular Therapy Laboratories for GMP-grade vaccine production. His research publications span neuro-oncology, immunology, and surgical innovation, with a strong translational focus. He actively leads national clinical trials and is deeply involved in education, mentoring students, residents, and fellows. He holds leadership roles in major professional societies, including the American Association of Neurological Surgeons (AANS) and Society for Neuro-Oncology. Listed in Who's Who in America Best Doctors in America Best Doctors in Canada Governor General's Gold Medal for Top PhD Graduate New Investigator Award Multiple research fellowships and bursaries Dr. Parney is actively involved in clinical trials, grant-funded research, and national committees, including the National Cancer Care Network CNS Panel. His lab operates at the intersection of surgery and immunology, aiming to improve outcomes for patients with glioblastoma. He is a member of multiple research groups, including the David F. and Margaret T. Grohne Cancer Immunology and Immunotherapeutics Program.
Kristoffer Vitting-Seerup is an Associate Professor at the Department of Health Technology , Technical University of Denmark, specializing in Bioinformatics and Isoform Analysis . His research focuses on leveraging RNA sequencing, alternative splicing, and protein domain variants to advance cancer genomics and neuro-oncology. Current academic rank: Associate Professor Key collaborations: DTU, University of Copenhagen, international cancer research teams Supervisory role: 5 PhD students in projects spanning machine learning for single-cell sequencing and isoform-level systems biology His work demonstrates strong emphasis on transcriptomics in glioblastoma, with recent publications analyzing tumor infiltration, neurodevelopmental pathways, and therapy resistance mechanisms. Articles reveal expertise in alternative splicing's role in biological signaling, protein domain functional diversity, and genomic stability in cancer stem cells. Research tools developed include satuRn for transcript usage analysis and IsoformSwitchAnalyzeR for splicing variant characterization. Current projects aim to improve clinical diagnostics through machine learning frameworks and enhance understanding of isoform-level biology in diseases. Advising: Rasmussen, M. N. (PhD Student, 2025-2028) Zhen, Z. T. (PhD Student, 2024-2027) Hsieh, C.-Y. (PhD Student, 2024-2027) Kanakoglou, D. S. (PhD Student, 2023-2026) Dam, S. H. (PhD Student, 2021-2025)
Kirsten Grønbæk serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Internal Medicine: Haematology. Her clinical and research work is centered at the Department of Clinical Medicine, with her laboratory group accessible through the BRIC research center website. Professor Grønbæk's research primarily focuses on hematological malignancies, with particular emphasis on lymphoma subtypes including mantle cell lymphoma and B-cell lymphoma, as well as myeloid malignancies. Her work spans molecular mechanisms of disease, therapeutic resistance, biomarker discovery, and clinical outcomes research. She employs approaches ranging from epigenetic analysis of DNA methylation patterns to population-based studies of treatment effectiveness in real-world settings. Her recent publication trends reveal strong focus on therapeutic resistance mechanisms, particularly in relation to novel immunotherapies like CD20xCD3 bispecific antibodies, and the development of improved diagnostic and prognostic tools for hematological malignancies. Her research frequently incorporates Danish nationwide population-based data, leveraging the comprehensive healthcare registries available in Denmark. Professor Grønbæk leads the Grønbæk Research Group, which maintains active collaborations both nationally and internationally as indicated by the extensive co-authorship on her publications. Her work demonstrates strong translational focus, bridging basic science discoveries with clinical applications in hematology and oncology.
Anja Lisbeth Frederiksen serves as Clinical Professor at Aalborg University's Faculty of Medicine within the Department of Clinical Genetics, while also holding the position of Overlæge (senior physician) at Aalborg University Hospital. Her research integrates clinical practice with academic investigation in mitochondrial disorders and genetic bone diseases. Education : Ph.D. in biomedical sciences (specific field not detailed) Research Focus : Dr. Frederiksen's work centers on: Mitochondrial DNA mutations (m.3243A>G, M.10010T>C) and their phenotypic expressions Bone density/turnover mechanisms in genetic disorders like hypophosphatasia Neurological manifestations including autonomic neuropathy Gastrointestinal dysmotility in mitochondrial disease Publication Trends : Recent work (2024-2025) demonstrates increasing focus on translational applications, with studies connecting mitochondrial dysfunction to bone pathology and gastrointestinal motility disorders. Her research shows strong interdisciplinary collaboration across neurology, endocrinology, and bone biology. Advising & Grants : She currently supervises PhD candidate Simone Rask Nielsen on an active project (2022-2026) investigating autonomic neuropathy in mitochondrial disease patients, indicating sustained grant funding and mentorship capacity. Professional Network : Collaborations with researchers like Inge Søkilde Pedersen and Christina Brock reflect her integrated role within Denmark's clinical genetics research ecosystem, particularly in mitochondrial disease pathophysiology.
Therese Ovesen serves as an Adjunct Professor within the Department of Regional Health Research at University of Southern Denmark, affiliated with IRS - Esbjerg and Grindsted Hospital's Research Unit of Otorhinolaryngology in Esbjerg. Her clinical and research activities focus on advancing ENT surgical techniques and patient outcomes through evidence-based approaches. Her research interests span multiple critical areas in Otorhinolaryngology including innovative thyroidectomy procedures using autofluorescence guidance, vestibular rehabilitation protocols for acute balance disorders, comparative analysis of tonsillectomy techniques, and staging systems for oral squamous cell carcinoma. Her work demonstrates particular attention to surgical safety, postoperative recovery, and implementation of new technologies in clinical practice. Recent publications reveal a strong emphasis on randomized controlled trials and systematic reviews that address practical clinical challenges. Her research output shows consistent collaboration with multidisciplinary teams across Danish medical institutions, with publications appearing in high-impact journals including JAMA Network Open and Frontiers in Neurology. Her work on autofluorescence-guided thyroidectomy represents significant innovation in reducing postoperative complications. Ovesen maintains active clinical research engagement as evidenced by her 2024 publications and ongoing study protocols. She appears to focus on translating research findings into practical clinical applications that improve surgical outcomes and patient safety in otolaryngological procedures.
Jeanette Krogh Petersen is a Clinical Associate Professor at the Research Unit for Pathology (Odense) under the Clinical Institute of the University of Southern Denmark. Her work focuses on epigenetics, DNA methylation, and tumor biology in central nervous system tumors, particularly glioblastoma and meningioma. She actively collaborates with multidisciplinary teams across institutions. Affiliation: Clinical Institute, University of Southern Denmark Role: Research Unit for Pathology (Odense) Research Interests: Epigenetic mechanisms in intracranial tumors Development of 3D in vitro tumor models Multiomic profiling of glioblastoma progression Genomic and molecular characterization of pituitary adenomas Recent Publication Trends: Her 2024-2025 work emphasizes advanced tumor modeling, epigenetic biomarkers, and neuroimaging integration for precision oncology. Collaboration Network: Partners in Denmark and international institutions, with focus areas in neuro-oncology, molecular pathology, and radiation biology.
Christina Christoffersen is an Associate Professor in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in the physiology of circulation, kidney and lung. Her research group focuses on apolipoproteins, lipid metabolism and atherosclerosis, with particular emphasis on the biological function of apolipoprotein M and its ligand Sphingosine-1-P. Her educational background includes: High School - Science from Naestved High School (1995) MD from University of Copenhagen (2003) PhD from Rigshospitalet, University of Copenhagen (2006) DMSc from Rigshospitalet, University of Copenhagen (2014) Dr. Christoffersen's research program investigates the role of apolipoprotein M in cardiovascular disease, lipid metabolism, and related conditions. Her work spans molecular mechanisms to clinical applications, with recent studies examining connections between lipid metabolism and diverse conditions including age-related macular degeneration, Alzheimer's disease, and chronic kidney disease. She utilizes both basic science approaches and clinical cohort studies to advance understanding of lipid-related pathologies. Her publication record shows a strong trend toward interdisciplinary research connecting lipid metabolism with diverse physiological systems. Recent articles demonstrate expanding applications of apolipoprotein M research into ophthalmology, neurology, and metabolic surgery, indicating growing recognition of the systemic importance of lipid signaling pathways. Her scientific achievements have been recognized with numerous awards: Multiple Young Investigator Awards from prestigious conferences Astrup Prize (2006) Overlæge Johan Boserup og Lise Boserups Hæderslegat (2010) Paper of the year award from the Scandinavian Society of Atherosclerosis Research (2012) Dr. Christoffersen has successfully supervised numerous students at various levels and secured substantial research funding from major Danish foundations. She serves as daily responsible for her research group and holds leadership positions including board membership in the Scandinavian Society for Atherosclerosis Research. Her laboratory maintains active collaborations across multiple disciplines, reflecting the interdisciplinary nature of modern biomedical research in lipid metabolism and cardiovascular disease.
